The activation of NRF2 exerts protective effects by ameliorating mitochondrial dysfunction, oxidative damage, inflammation, and fibrosis in various renal diseases, including AKI, CKD, and diabetic nephropathy, which highlights NRF2 antioxidant pathway as an important target for kidney disease treatment [20,21]. This evidence concerns the gene NFE2L2 and diabetic kidney disease.